what is compounded semaglutide (GLP-1) Troubling Findings in Study of

Semaglutide may help some individuals reduce their alcohol use on days where they have at least 1 drink while also reducing cravings for alcohol

Safety considerations for retatrutide research Responsible research requires thorough safety understanding regardless of vendor selection

If the FDA finalizes its April 30, 2026 proposal to exclude semaglutide and tirzepatide from the 503B Bulks List, large-scale 503B compounding of those medications would no longer be legally permissible

Some participants have lost up to 24% of their body weight

The ongoing evaluation of Monlunabant aims to optimize its benefits while minimizing adverse effects, ensuring it remains a viable choice for long-term weight management

Expert-Guided, Sustainable Weight Loss Discover how proven medications such as semaglutide or tirzepatide, combined with expert support, can help you reach lasting weight loss results